Details:

Alternative Title:
MMWR Morb Mortal Wkly Rep
Personal Author:
Bocchini, Joseph A. ; Rubin, Lorry ; Fischer, Marc ; Hills, Susan L. ; Staples, J. Erin
Bocchini, Joseph A. ; Rubin, Lorry ; Fischer, Marc ; Hills, Susan L. ; Staples, J. Erin Less -
Corporate Authors:
United States. Advisory Committee on Immunization Practices.
Description:
On June 19, 2013, the Advisory Committee on Immunization Practices (ACIP) voted to extend existing recommendations for use of inactivated Vero cell culture-derived Japanese encephalitis (JE) vaccine (JE-VC) (Ixiaro, Intercell Biomedical) to include children aged 2 months through 16 years. The ACIP JE Vaccine Workgroup reviewed the epidemiology of JE in travelers and evaluated published and unpublished data on JE-VC immunogenicity and safety in adults and children. The evidence for benefits and risks associated with JE-VC vaccination of children was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework. This report summarizes the evidence considered by ACIP and outlines the recommendations for use of JE-VC in children traveling to JE-endemic countries.
Subject:
[+]
Adolescent
Advisory Committees
Articles
Child
Child, Preschool
Encephalitis, Japanese
Humans
Immunization Schedule
Infant
Japanese Encephalitis Vaccines
Randomized Controlled Trials As Topic
Risk Assessment
Travel
Vaccines, Inactivated

Source:
MMWR Morb Mortal Wkly Rep. 2013; 62(45):898-900.
Pubmed ID:
24226626
Pubmed Central ID:
PMC4585349
Document Type:
Journal Article
Place as Subject:
United States
Collection(s):
Advisory Committee on Immunization Practices (ACIP)
Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:
[+]
urn:sha256:049a42506950804bcf1ad93377883cdd2760d3619ed7b0a4ed3fa872447d430f
File Type:

Supporting Files

• 898-900.nxml

  xml

More +